---
title: "Xeltis announces US FDA Breakthrough Device Designation for aXess and first patient treated in US pivotal trial"
date: "2024-11-18T11:14:08.000Z"
publishedDate: "18 novembre 2024"
summary: "Xeltis has today announced that the Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA) has granted aXess Breakthrough Device Designation status. aXess is Xeltis’ vascular access conduit, which enables the creation of a new, permanent, living vessel for haemodialysis vascular access."
importance: ""
sourceUrl: "https://interventionalnews.com/xeltis-announces-us-fda-breakthrough-device-designation-for-axess-and-first-patient-treated-in-us-pivotal-trial/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2024-11-18-xeltis-announces-us-fda-breakthrough-device-designation-for-axess-and-first-patient-treated-in-us-pivotal-trial"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2024/11/xeltis-logo-featured.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/xeltis-announces-us-fda-breakthrough-device-designation-for-axess-and-first-patient-treated-in-us-pivotal-trial/"
---

![Xeltis announces US FDA Breakthrough Device Designation for aXess and first patient treated in US pivotal trial](https://interventionalnews.com/wp-content/uploads/sites/13/2024/11/xeltis-logo-featured.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/xeltis-announces-us-fda-breakthrough-device-designation-for-axess-and-first-patient-treated-in-us-pivotal-trial/*

## L’essentiel

Xeltis has today announced that the Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA) has granted aXess Breakthrough Device Designation status. aXess is Xeltis’ vascular access conduit, which enables the creation of a new, permanent, living vessel for haemodialysis vascular access.

## Lien source

https://interventionalnews.com/xeltis-announces-us-fda-breakthrough-device-designation-for-axess-and-first-patient-treated-in-us-pivotal-trial/
